miR-22 directly binds to the 3′UTR of ELAVL1 leading to its inhibition, which, in turn, represses CRC proliferation and migration in vitro and decelerates CRC xenografted tumor growth in vivo (5). Here, ELAVL1 is linked to colorectal carcinoma.